Follow us on Twitter
twitter icon@FreshPatents

Tension Headache patents

Bulk PDF Downloads
      

This page is updated frequently with new Tension Headache-related patent applications.




 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same patent thumbnailAntagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-cgrp antagonist antibody. Antagonist antibody g1 and antibodies derived from g1 directed to cgrp are also described..
Labrys Biologics, Inc.


 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same patent thumbnailAntagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-cgrp antagonist antibody. Antagonist antibody g1 and antibodies derived from g1 directed to cgrp are also described..
Labrys Biologics, Inc.


 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same patent thumbnailAntagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-cgrp antagonist antibody. Antagonist antibody g1 and antibodies derived from g1 directed to cgrp are also described..
Labrys Biologics, Inc.


 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same patent thumbnailAntagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-cgrp antagonist antibody. Antagonist antibody g1 and antibodies derived from g1 directed to cgrp are also described..
Labrys Biologics, Inc.


 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same patent thumbnailAntagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-cgrp antagonist antibody. Compositions for use in the disclosed methods are also provided.
Labrys Biologics, Inc.


 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same patent thumbnailAntagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-cgrp antagonist antibody. Antagonist antibody g1 and antibodies derived from g1 directed to cgrp are also described..

 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same patent thumbnailAntagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms and/or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-cgrp antagonist antibody. Compositions for use in the disclosed methods are also provided.
Labrys Biologics, Inc.


 Apparatus for treating cerebral neurovascular disorders including headaches by neural stimulation patent thumbnailApparatus for treating cerebral neurovascular disorders including headaches by neural stimulation
Methods, kits, apparatus, and compositions for inhibiting a cerebral neurovascular disorder, a muscular headache, or cerebral inflammation in a human patient are provided. The apparatus includes an electronic neural stimulator capable of stimulating a dorsonasal nerve structure associated with pain in a subject, thereby inhibiting the pain, and includes a power supply for providing the neural stimulation; and at least one electrical conduit coupled between the power supply and a dorsonasal nerve structure associated with the cerebral neurovascular disorder in a manner to transmit the neural stimulation to the dorsonasal nerve structure associated with the pain to thereby inhibit the pain.

 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same patent thumbnailAntagonist antibodies directed against calcitonin gene-related peptide and methods using same
The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-cgrp antagonist antibody. Antagonist antibody g1 and antibodies derived from g1 directed to cgrp are also described..
Labrys Biologics, Inc.


 Topical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions patent thumbnailTopical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions
The invention is directed to topical formulations and methods of treating a migraines and/or cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches, tension related migraines and related conditions associated with muscle tension and pain with a therapeutically effective amount of an ergot alkaloid, skeletal muscle relaxant, serotonin agonist, combinations thereof, pharmaceutically acceptable salt thereof, prodrugs thereof or derivative thereof.. .
Afgin Pharma Llc


Apparatus for treating cerebral neurovascular disorders including headaches by neural stimulation


Methods, kits, apparatus, and compositions for inhibiting a cerebral neurovascular disorder, a muscular headache, or cerebral inflammation in a human patient are provided. The apparatus includes an electronic neural stimulator capable of stimulating a dorsonasal nerve structure associated with pain in a subject, thereby inhibiting the pain, and includes a power supply for providing the neural stimulation; and at least one electrical conduit coupled between the power supply and a dorsonasal nerve structure associated with the cerebral neurovascular disorder in a manner to transmit the neural stimulation to the dorsonasal nerve structure associated with the pain to thereby inhibit the pain.

Methods of treating vasomotor symptoms using antibodies


The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-cgrp antagonist antibody. Antagonist antibody g1 and antibodies derived from g1 directed to cgrp are also described..

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same


The invention features methods for preventing or treating cgrp associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-cgrp antagonist antibody. Antagonist antibody g1 and antibodies derived from g1 directed to cgrp are also described..

Tension release technique


The present invention is a manual, medicine, therapy technique that provides a guide to evaluate soft tissue impairment and guidelines to treat muscle tension, muscle pain, soft tissue pain, trigger points, and tension headaches through stimulating the golgi tendon organs.. .

Method for directed intranasal administration of a composition


Methods, kits, apparatus, and compositions for inhibiting a cerebral neurovascular disorder, a muscular headache, or cerebral inflammation in a human patient are provided. The methods comprise intranasally administering to the patient a pharmaceutical composition comprising a local anesthetic, and preferably a long-acting local anesthetic ingredient.



Tension Headache topics:
  • Tension Headache
  • Cluster Headache
  • Calcitonin
  • Antagonist
  • Antibodies
  • Guidelines
  • Muscle Contraction
  • Local Anesthetic
  • Anesthetic
  • Inflammation
  • Contraction
  • Spasticity
  • Skeletal Muscle


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Tension Headache for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Tension Headache with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.3121

    829

    0 - 1 - 16